Advertisement

Topics

PubMed Journals Articles About "Global Head Neck Cancer Partnering 2010 2017 Updated" RSS

03:10 EDT 20th September 2018 | BioPortfolio

Global Head Neck Cancer Partnering 2010 2017 Updated PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Global Head Neck Cancer Partnering 2010 2017 Updated articles that have been published worldwide.

More Information about "Global Head Neck Cancer Partnering 2010 2017 Updated" on BioPortfolio

We have published hundreds of Global Head Neck Cancer Partnering 2010 2017 Updated news stories on BioPortfolio along with dozens of Global Head Neck Cancer Partnering 2010 2017 Updated Clinical Trials and PubMed Articles about Global Head Neck Cancer Partnering 2010 2017 Updated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Head Neck Cancer Partnering 2010 2017 Updated Companies in our database. You can also find out about relevant Global Head Neck Cancer Partnering 2010 2017 Updated Drugs and Medications on this site too.

Showing "Global Head Neck Cancer Partnering 2010 2017 Updated" PubMed Articles 1–25 of 25,000+

Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from head and neck 5000.

Tobacco and alcohol consumption are risk factors for developing head and neck cancer, and continuation postdiagnosis can adversely affect prognosis. We explored changes to these behaviors after a head and neck cancer diagnosis.


Physical Therapy Challenges in Head and Neck Cancer.

Treatment sequelae such as trismus, shoulder dysfunction syndrome resulting from spinal accessory nerve palsy, and radiotherapy-induced neck fibrosis are often overlooked when in the management of head and neck cancer patients. This chapter examines these underappreciated issues and their corresponding physical therapy intervention based on current evidence. Head and neck cancer survivors must contend with these disabilities for years after treatment has been concluded. A few quit their jobs which puts a tr...

Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.

Postoperative chemoradiotherapy (CRT) is considered standard of care in patients with locally advanced head and neck cancer with positive margins and/or extracapsular extension (ECE).


Perineural Invasion in Head and Neck Cancer.

Perineural invasion (PNI) is a mechanism of tumor dissemination that can provide a challenge to tumor eradication and that is correlated with poor survival. Squamous cell carcinoma, the most common type of head and neck cancer, has a high prevalence of PNI. This review provides an overview of clinical studies on the outcomes and factors associated with PNI in head and neck cancer and on findings on cancer-nerve crosstalk.

Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.

Information on re-irradiation (re-RT) for recurrent and second primary head and neck cancer is limited. Herein, a description of our long-term experience of re-RT for previously irradiated head and neck cancer is provided.

Evaluation of a rehabilitation planning consult for survivors of head and neck cancer.

The rehabilitation planning consult (RPC) is a novel, transdisciplinary rehabilitation intervention for survivors of head and neck cancer. The study aimed to: (1) estimate recruitment and withdrawal rates, and adverse events; and (2) estimate the effect on rehabilitation indicators in survivors of head and neck cancer.

Head and Neck Reconstructive Surgery.

Head and neck reconstruction following surgical extirpative management of head and neck cancer requires critical assessment and meticulous correction of both aesthetic and functional deficits to optimize the physical and psychological well-being of the patient. Unique to head and neck cancers is the potential alteration of one's senses, breathing, speech, and swallowing functions, as well as overall head and neck aesthetics. When possible, tissue defects are replaced with similar tissues, though donor sites...

A web-based prediction score for head and neck cancer referrals.

Following the announcement of the NHS Cancer Plan in 2000, anyone suspected of having cancer has to be seen by a specialist within two weeks of referral. Since this introduction, studies have shown that only 6.3-14.6% of 2-week referrals were diagnosed with a head and neck cancer and that majority of the cancer diagnoses were via other referral routes. These studies suggest that the referral scheme is not currently cost effective. Our aim is to develop a scoring system that determines the risk of head and ...

Surgical Perspectives in Head and Neck Cancer.

Head and neck cancer treatment is a complex multidisciplinary undertaking. Cancer cure and survival is a primary goal, yet safe-guarding appearance and function to preserve the quality of life are similarly critical. The head and neck surgeon remains central to multidisciplinary cancer care, with deep knowledge of operative technique and an even deeper understanding of cancer biology. The surgeon models practice based on the highest levels of scientific evidence, but also takes into consideration the approa...

Role of the Speech-Language Pathologist (SLP) in the Head and Neck Cancer Team.

While treatments for head and neck cancer are aimed at curing patients from disease, they can have significant short- and long-term negative impacts on speech and swallowing functions. Research demonstrates that early and frequent involvement of Speech-Language Pathologists (SLPs) is beneficial to these functions and overall quality of life for head and neck cancer patients. Strategies and tools to optimize communication and safe swallowing are presented in this chapter.

Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.

As high-dose-rate (HDR) brachytherapy can preferentially spare normal anatomic structures surrounding the radiation target, we report on our experience using this technique in head and neck cancer reirradiation.

FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.

The utility of fluorodeoxyglucose positron emission tomography (FDG-PET) imaging to predict outcome has been well-established for patients undergoing definitive radiation in the initial management of head and neck cancer. However, the usefulness of this modality in the recurrent setting remains uncertain. We sought to evaluate the prognostic value of metabolic tumor parameters measured on FDG-PET in patients treated by reirradiation for recurrent head and neck cancer.

Corrigendum.

Vila PM, Zenga J, Fowler S, Jackson RS. Antibiotic prophylaxis in clean-contaminated head and neck surgery: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2017;157:580-588. (Original DOI: 10.1177/0194599817712215) This article was printed in the October 2017 issue with the third author, Susan Fowler, omitted. The online version of this article has been corrected to accurately reflect Susan Fowler's authorship: Susan Fowler's name was added as the third author in the byline and her affili...

What does the 4th edition of the World Health Organization Classification of Head and Neck Tumors (2017) bring new about mucosal melanomas?

The recently published 4th Edition of the World Health Organization Classification of Head and Neck Tumors addresses the most relevant and updated aspects of tumor biology, including clinical presentation, histopathology, immunohistochemistry, and prognosis of head and neck tumors. The objective of the present study is to compare these updates to the 3rd edition of that book with regard to mucosal melanomas and to highlight the potential factors that differ those tumors from cutaneous melanomas. We observed...

Quality of life of head and neck cancer patients in urban and regional areas: An Australian perspective.

Head and neck cancer treatment affects quality of life. There are differences in quality of life outcomes and perceived supportive care needs between cancer patients living in metropolitan and regional-remote areas. This study investigated quality of life over the first 6 months following head and neck cancer diagnosis and observed differences in quality of life by geographical location.

Opioid Prescription Patterns Among Patients With Head and Neck Cancer.

Multidisciplinary Clinical Treatment of Head and Neck Cancer-Reply.

Multidisciplinary Clinical Treatment of Head and Neck Cancer.

Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.

This study examined the relationships of depressive symptoms and social anxiety with perceived neck function in patients treated for head and neck cancer.

Case-control study of oral disease indexes in individuals with head and neck cancer after antineoplastic therapy.

To evaluate the oral health of patients with head and neck cancer after antineoplastic treatment, and to compare them with patients with no history of cancer.

Accuracy of the HPV status site-specific factor 10 (SSF-10) variable for patients with oropharyngeal cancers in the Iowa Cancer Registry, 2010-2014.

Surveillance, Epidemiology, and End Results Cancer Registries (SEER) began collecting human papillomavirus (HPV) status for upper aerodigestive tract cancers in 2010. However, classification of p16-testing was not included in the Collaborative Stage coding guidelines, potentially leading to inconsistent coding.

Support Needs of People With Head and Neck Cancer Regarding the Disease and Its Treatment.

To provide insight into people's experiences in dealing with the consequences of head and neck cancer (HNC) in daily life and their needs for self-management support.

Head and neck cancer: validation of a data collection instrument.

construct and validate the content of an instrument to collect data from patients with head and neck cancer (HNC) served in a specialty clinic.

Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma.

The TNM classification is a worldwide standard staging system used to define the extent of cancer and is a major prognostic factor in predicting the outcome of patients. The TNM Classification of Malignant Tumours, 8th edition, has been used since January 1, 2018. In the area of head and neck cancer major modifications were produced: important updated T and N modification for oral cavity and nasopharyngeal cancer, the introduction of clinical and pathological stages for neck disease, and a new HPV-16-positi...

Global Estimate of Lung Cancer Mortality Attributable to Residential Radon.

Radon is the second most important cause of lung cancer, ranked by the World Health Organization as the fifth leading cause of mortality in 2010. An updated database of national radon exposures for 66 countries allows the global burden of lung cancer mortality attributable to radon to be estimated.


Advertisement
Quick Search
Advertisement
Advertisement